Lv2
130 积分 2023-08-30 加入
TGF-β-activated NK-92 cell therapy for esophageal squamous cell carcinoma
2个月前
已完结
STAT1 acts as a tumor promoter for leukemia development
5个月前
已完结
Cancer immunoediting and resistance to T cell-based immunotherapy
9个月前
已完结
Cancer immunoediting and resistance to T cell-based immunotherapy
9个月前
已完结
Cancer immune evasion, immunoediting and intratumour heterogeneity
9个月前
已完结